Quick Answer
IRIDEX CORP reported Cash and Equivalents of $2.39 million for fiscal year 2024.
IRIDEX CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $2.39M | -66.1% |
| 2023 | $7.03M | -49.5% |
| 2022 | $13.92M | -41.6% |
| 2021 | $23.85M | +105.2% |
| 2020 | $11.63M | -8.1% |
| 2019 | $12.65M | -40.3% |
| 2018 | $21.19M | -2.4% |
| 2017 | $21.71M | -8.6% |
| 2016 | $23.75M | +137.6% |
| 2015 | $9.99M | -24.9% |
| 2014 | $13.30M | -1.0% |
| 2013 | $13.44M | +13.0% |
| 2012 | $11.90M | +10.3% |
| 2011 | $10.79M | +29.3% |
| 2010 | $8.35M | -0.2% |
| 2009 | $8.37M | +86.8% |
| 2008 | $4.48M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.57M | +44.4% | -17.8% |
| June 30, 2025 | $6.78M | +64.9% | -6.4% |
| March 31, 2025 | $7.24M | +33.7% | +203.5% |
| December 31, 2024 | $2.39M | -66.1% | -38.2% |
| September 30, 2024 | $3.86M | -51.6% | -6.1% |
| June 30, 2024 | $4.11M | -58.1% | -24.1% |
| March 31, 2024 | $5.42M | -51.0% | -23.0% |
| December 31, 2023 | $7.03M | -49.5% | -11.9% |
- IRIDEX CORP showed a decrease of -66.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2024 period, IRIDEX CORP’s cash and equivalents has declined by 46.7% (from $4.48 million to $2.39 million).
- The most recent figure is from IRIDEX CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: